|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM,
Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, Dupont N, et al:
Uterine neoplasms, version 1.2014. J Natl Compr Canc Netw.
12:248–280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zannoni GF, Scambia G and Gallo D: The
dualistic model of endometrial cancer: The challenge of classifying
grade 3 endometrioid carcinoma. Gynecol Oncol. 127:262–263. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amant F, Cadron I, Fuso L, Berteloot P, de
Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P and Vergote
I: Endometrial carcinosarcomas have a different prognosis and
pattern of spread compared to high-risk epithelial endometrial
cancer. Gynecol Oncol. 98:274–280. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lajer H, Elnegaard S, Christensen RD,
Ortoft G, Schledermann DE and Mogensen O: Survival after stage IA
endometrial cancer; can follow-up be altered? A prospective
nationwide Danish survey. Acta Obstet Gynecol Scand. 91:976–982.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kitchener HC and Trimble EL: Endometrial
Cancer Working Group of the Gynecologic Cancer Intergroup:
Endometrial cancer state of the science meeting. Int J Gynecol
Cancer. 19:134–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Torricelli F, Nicoli D, Bellazzi R,
Ciarrocchi A, Farnetti E, Mastrofilippo V, Zamponi R, La Sala GB,
Casali B and Mandato VD: Computational development of a
molecular-based approach to improve risk stratification of
endometrial cancer patients. Oncotarget. 9:25517–25528. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee PJ, McNulty S, Duncavage EJ, Heusel JW
and Hagemann IS: Clinical targeted next-generation sequencing shows
increased mutational load in endometrioid-type endometrial
adenocarcinoma with deficient DNA mismatch repair. Int J Gynecol
Pathol. 37:581–589. 2017.
|
|
10
|
DeLair DF, Burke KA, Selenica P, Lim RS,
Scott SN, Middha S, Mohanty AS, Cheng DT, Berger MF, Soslow RA and
Weigelt B: The genetic landscape of endometrial clear cell
carcinomas. J Pathol. 243:230–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zighelboim I, Schmidt AP, Gao F, Thaker
PH, Powell MA, Rader JS, Gibb RK, Mutch DG and Goodfellow PJ: ATR
mutation in endometrioid endometrial cancer is associated with poor
clinical outcomes. J Clin Oncol. 27:3091–3096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cancer Genome Atlas Research Network, ;
Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H,
Robertson AG, Pashtan I, Shen R, et al: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Talhouk A, McConechy MK, Leung S, Li-Chang
HH, Kwon JS, Melnyk N, Yang W, Senz J, Boyd N, Karnezis AN, et al:
A clinically applicable molecular-based classification for
endometrial cancers. Br J Cancer. 113:299–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
ENCODE Project Consortium. An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gibb EA, Vucic EA, Enfield KS, Stewart GL,
Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S,
Brown CJ, et al: Human cancer long non-coding RNA transcriptomes.
PLoS One. 6:e259152011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Angrand PO, Vennin C, Le Bourhis X and
Adriaenssens E: The role of long non-coding RNAs in genome
formatting and expression. Front Genet. 6:1652015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
St Laurent G, Wahlestedt C and Kapranov P:
The landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ravo M, Cordella A, Rinaldi A, Bruno G,
Alexandrova E, Saggese P, Nassa G, Giurato G, Tarallo R, Marchese
G, et al: Small non-coding RNA deregulation in endometrial
carcinogenesis. Oncotarget. 6:4677–4691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nassa G, Giurato G, Cimmino G, Rizzo F,
Ravo M, Salvati A, Nyman TA, Zhu Y, Vesterlund M, Lehtiö J, et al:
Splicing of platelet resident pre-mRNAs upon activation by
physiological stimuli results in functionally relevant proteome
modifications. Sci Rep. 8:4982018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tarallo R, Giurato G, Bruno G, Ravo M,
Rizzo F, Salvati A, Ricciardi L, Marchese G, Cordella A, Rocco T,
et al: The nuclear receptor ERbeta engages AGO2 in regulation of
gene transcription, RNA splicing and RISC loading. Genome Biol.
18:1892017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dobin A, Davis CA, Schlesinger F, Drenkow
J, Zaleski C, Jha S, Batut P, Chaisson M and Gingeras TR: STAR:
Ultrafast universal RNA-seq aligner. Bioinformatics. 29:15–21.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Anders S, Pyl PT and Huber W: HTSeq-a
Python framework to work with high-throughput sequencing data.
Bioinformatics. 31:166–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gaujoux R and Seoighe C: A flexible R
package for nonnegative matrix factorization. BMC Bioinformatics.
11:3672010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang W, Zhuang Q, Ji K, Wen B, Lin P, Zhao
Y, Li W and Yan C: Identification of miRNA, lncRNA and
mRNA-associated ceRNA networks and potential biomarker for MELAS
with mitochondrial DNA A3243G mutation. Sci Rep. 7:416392017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao Z, Bai J, Wu A, Wang Y, Zhang J, Wang
Z, Li Y, Xu J and Li X: Co-LncRNA: Investigating the lncRNA
combinatorial effects in GO annotations and KEGG pathways based on
human RNA-Seq data. Database. 2015:bav0822015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Talhouk A and McAlpine JN: New
classification of endometrial cancers: The development and
potential applications of genomic-based classification in research
and clinical care. Gynecol Oncol Res Pract. 3:142016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vallone C, Rigon G, Gulia C, Baffa A,
Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, et
al: Non-coding RNAs and endometrial cancer. Genes. 9:E1872018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu J, Qian Y, Ye M, Fu Z, Jia X, Li W, Xu
P, Lv M, Huang L, Wang L, et al: Distinct expression profile of
lncRNA in endometrial carcinoma. Oncol Rep. 36:3405–3412. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen BJ, Byrne FL, Takenaka K, Modesitt
SC, Olzomer EM, Mills JD, Farrell R, Hoehn KL and Janitz M:
Transcriptome landscape of long intergenic non-coding RNAs in
endometrial cancer. Gynecol Oncol. 147:654–662. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang J, Ke P, Guo L, Wang W, Tan H, Liang
Y and Yao S: Lentivirus-mediated RNA interference targeting the
long noncoding RNA HOTAIR inhibits proliferation and invasion of
endometrial carcinoma cells in vitro and in vivo. Int J Gynecol
Cancer. 24:635–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shang C, Lang B, Ao CN and Meng L: Long
non-coding RNA tumor suppressor candidate 7 advances chemotherapy
sensitivity of endometrial carcinoma through targeted silencing of
miR-23b. Tumour Biol. 39:10104283177078832017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sun KX, Wu DD, Chen S, Zhao Y and Zong ZH:
LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and
progression through PI3K pathway. Apoptosis. 22:1543–1552. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang D, Wang D, Wang N, Long Z and Ren X:
Long non-coding RNA BANCR promotes endometrial cancer cell
proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK
signaling pathway. Cell Physiol Biochem. 40:644–656. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang L, Zhang J, Jiang A, Liu Q, Li C,
Yang C and Xiu J: Expression profile of long non-coding RNAs is
altered in endometrial cancer. Int J Clin Exp Med. 8:5010–5021.
2015.PubMed/NCBI
|
|
43
|
Xin W, Liu X, Ding J, Zhao J, Zhou Y, Wu Q
and Hua K: Long non-coding RNA derived miR-205-5p modulates human
endometrial cancer by targeting PTEN. Am J Transl Res. 7:2433–2441.
2015.PubMed/NCBI
|
|
44
|
Zhai W, Li X, Wu S, Zhang Y, Pang H and
Chen W: Microarray expression profile of lncRNAs and the
upregulated ASLNC04080 lncRNA in human endometrial carcinoma. Int J
Oncol. 46:2125–2137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cheng DL, Xiang YY, Ji LJ and Lu XJ:
Competing endogenous RNA interplay in cancer: Mechanism,
methodology, and perspectives. Tumour Biol. 36:479–488. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lu M, Xu X, Xi B, Dai Q, Li C, Su L, Zhou
X, Tang M, Yao Y and Yang J: Molecular network-based identification
of competing endogenous RNAs in thyroid carcinoma. Genes.
9:E442018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu C, Zhang YH, Deng Q, Li Y, Huang T,
Zhou S and Cai YD: Cancer-related triplets of mRNA-lncRNA-miRNA
revealed by integrative network in uterine corpus endometrial
carcinoma. Biomed Res Int. 2017:38595822017.PubMed/NCBI
|
|
50
|
Jia H, Zhang Z, Zou D, Wang B, Yan Y, Luo
M, Dong L, Yin H, Gong B, Li Z, et al: MicroRNA-10a is
down-regulated by DNA methylation and functions as a tumor
suppressor in gastric cancer cells. PLoS One. 9:e880572014.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zou D, Zhou Q, Wang D, Guan L, Yuan L and
Li S: The downregulation of MicroRNA-10b and its role in cervical
cancer. Oncol Res. 24:99–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Snowdon J, Zhang X, Childs T, Tron VA and
Feilotter H: The microRNA-200 family is upregulated in endometrial
carcinoma. PLoS One. 6:e228282011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Panda H, Pelakh L, Chuang TD, Luo X,
Bukulmez O and Chegini N: Endometrial miR-200c is altered during
transformation into cancerous states and targets the expression of
ZEBsVEGFAFLT1IKKbetaKLF9, and FBLN5. Reprod Sci.
19:786–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Korani M, Fallah S, Tehranian A,
Nourbakhsh M, Samadikuchaksaraei A, Pour MS and Maleki J: The
evaluation of the FOXO1, KLF9 and YT521 genes expression in human
endometrial cancer. Clin Lab. 59:483–489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Simmons CD, Pabona JM, Heard ME, Friedman
TM, Spataro MT, Godley AL, Simmen FA, Burnett AF and Simmen RC:
Krüppel-like factor 9 loss-of-expression in human endometrial
carcinoma links altered expression of growth-regulatory genes with
aberrant proliferative response to estrogen. Biol Reprod.
85:378–385. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu Y, Nan F, Lu K and Wang Y, Liu Y, Wei
S, Wu R and Wang Y: Identification of key genes in endometrioid
endometrial adenocarcinoma via TCGA database. Cancer Biomark.
21:11–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Honkavuori-Toivola M, Santala M, Soini Y,
Turpeenniemi- Hujanen T and Talvensaari-Mattila A: Combination of
strong MMP-2 and weak TIMP-2 immunostainings is a significant
prognostic factor in endometrial carcinoma. Dis Markers.
35:261–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Dai Y, Xia W, Song T, Su X, Li J, Li S,
Chen Y, Wang W, Ding H, Liu X, et al: MicroRNA-200b is
overexpressed in endometrial adenocarcinomas and enhances
MMP2 activity by downregulating TIMP2 in human
endometrial cancer cell line HEC-1A cells. Nucleic Acid Ther.
23:29–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Liu C, Yang Z, Deng Z, Zhou Y, Gong Q,
Zhao R and Chen T: Upregulated lncRNA ADAMTS9-AS2 suppresses
progression of lung cancer through inhibition of miR-223-3p and
promotion of TGFBR3. IUBMB Life. 70:536–546. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yao J, Zhou B, Zhang J, Geng P, Liu K, Zhu
Y and Zhu W: A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated
by DNMT1 and inhibits migration of glioma cells. Tumour Biol.
35:7935–7944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Guo Q, Qian Z, Yan D, Li L and Huang L:
LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by
repressing Notch signaling. Biomed Pharmacother. 82:589–594. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Terashima M, Tange S, Ishimura A and
Suzuki T: MEG3 long noncoding RNA contributes to the epigenetic
regulation of epithelial-mesenchymal transition in lung cancer cell
lines. J Biol Chem. 292:82–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yang X, Wang CC, Lee WYW, Trovik J, Chung
TKH and Kwong J: Long non-coding RNA HAND2-AS1 inhibits invasion
and metastasis in endometrioid endometrial carcinoma through
inactivating neuromedin U. Cancer Lett. 413:23–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wang H, Niu L, Jiang S, Zhai J, Wang P,
Kong F and Jin X: Comprehensive analysis of aberrantly expressed
profiles of lncRNAs and miRNAs with associated ceRNA network in
muscle-invasive bladder cancer. Oncotarget. 7:86174–86185. 2016.
View Article : Google Scholar : PubMed/NCBI
|
